Item
|
Groups
|
--P--
|
---|
Control
|
Sildenafil
|
Mucuna pruriens
|
Tribulus terrestris
|
Ashwagandha
|
---|
Final body weight, g
|
324.00 ± 24.84
|
316.57 ± 17.99
|
312.00 ± 29.73
|
307.71 ± 52.45
|
331.80 ± 28.31
|
>0.05
|
Testis, g
|
1.39 ± 0.07
|
1.35 ± 0.11
|
1.35 ± 0.09
|
1.36 ± 0.14
|
1.33 ± 0.08
|
>0.05
|
Whole epididymis, g
|
0.58 ± 0.05
|
0.61 ± 0.04
|
0.56 ± 0.05
|
0.58 ± 0.07
|
0.59 ± 0.04
|
>0.05
|
Right cauda epididymis, g
|
0.25 ± 0.03
|
0.24 ± 0.03
|
0.24 ± 0.03
|
0.23 ± 0.05
|
0.23 ± 0.02
|
>0.05
|
Vas deferens, g
|
0.12 ± 0.01
|
0.13 ± 0.01
|
0.12 ± 0.01
|
0.13 ± 0.01
|
0.13 ± 0.01
|
>0.05
|
Seminal vesicles, g
|
1.16 ± 0.30
|
1.10 ± 0.25
|
1.09 ± 0.18
|
1.17 ± 0.24
|
1.39 ± 0.31
|
>0.05
|
Ventral prostate, g
|
0.43 ± 0.07
|
0.49 ± 0.07
|
0.41 ± 0.07
|
0.50 ± 0.17
|
0.48 ± 0.18
|
>0.05
|
Testis*, %
|
0.43 ± 0.04
|
0.43 ± 0.04
|
0.43 ± 0.05
|
0.45 ± 0.05
|
0.40 ± 0.03
|
>0.05
|
Whole epididymis*, %
|
0.18 ± 0.02
|
0.19 ± 0.02
|
0.18 ± 0.02
|
0.19 ± 0.02
|
0.18 ± 0.01
|
>0.05
|
Right cauda epididymis*, %
|
0.08 ± 0.01
|
0.08 ± 0.01
|
0.08 ± 0.01
|
0.08 ± 0.01
|
0.07 ± 0.004
|
>0.05
|
Vas deferens*, %
|
0.04 ± 0.005
|
0.04 ± 0.008
|
0.04 ± 0.003
|
0.04 ± 0.007
|
0.04 ± 0.004
|
>0.05
|
Seminal vesicles*, %
|
0.36 ± 0.09
|
0.35 ± 0.09
|
0.35 ± 0.05
|
0.38 ± 0.06
|
0.42 ± 0.9
|
>0.05
|
Ventral prostate*, %
|
0.13 ± 0.02
|
0.15 ± 0.02
|
0.13 ± 0.02
|
0.16 ± 0.04
|
0.14 ± 0.05
|
>0.05
|
- *Relative reproductive organ weights [organ weight (g) / final body weight (g) X 100]
- Control, no treatment; Sildenafil, rats treated with Sildenafil (5 mg/kg/d); Mucuna, rats treated with Mucuna pruriens (300 mg/kg bw); Tribulus; rats treated with Tribulus terrestris (300 mg/kg bw); Ashwagandha; rats treated with Ashwagandha (300 mg/kg bw). Data are LS means ± SE (n = 7). Different superscripts in the same row (a–c) indicate group mean differences (p < 0.05)